Uqar spinout Ovensa has obtained $1.38m of additional funding from investors including commercialisation firm Aligo Innovation.

Bill & Melinda Gates Foundation will invest up to $40m in the biological drug developer, which raised $320m in an Eli Lilly-backed round two years ago.

WuXi Healthcare Ventures has led a first funding round for LifeMine Therapeutics, based on research by Harvard University profressor Gregory Verdine.

Ascension Health and Wilson, Sonsini, Goodrich & Rosati contributed to the oncology therapy developer's series A round, which was led by Menlo Ventures.

Bill & Melinda Gates Foundation will invest up to $40m in the biological drug developer, which raised $320m in an Eli Lilly-backed round two years ago.

The surgery robotics developer has added $26m from investors including Cambridge Innovation Capital to complete its series A round, 14 months after closing the first tranche.

WuXi Healthcare Ventures has led a first funding round for LifeMine Therapeutics that also featured GV and Merck Ventures.

Imstem Biotechnology, a spinout from Connecticut, has won a patent for its stem cell-based treatment of autoimmune diseases such as multiple sclerosis.